Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of LUM 001 in adults with primary sclerosing cholangitis (PSC)

Next Previous
X
Search
Trial Profile

Phase II trial of LUM 001 in adults with primary sclerosing cholangitis (PSC)

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2013

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Maralixibat (Primary)
  • Indications Primary sclerosing cholangitis
  • Focus Therapeutic Use
  • Sponsors Lumena Pharmaceuticals

    • Most Recent Events

    • 04 Oct 2013 New trial record
    • 26 Sep 2013 This trial is expected to begin later in 2013, according to a Lumena Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top